Opinion of the High Council for Public Health dated December 17, 2010, regarding the mandatory minimum information requirements for advertising the intradermal seasonal influenza vaccine Intanza® 15 µg
Author(s): Haut Conseil de la Santé Publique
Publishing year: 2011
Pages: 152
Weekly Epidemiological Bulletin, 2011, n° 10-11, p. 152
In relation to
Our latest news
news
Call for Applications for the Renewal of the Editorial Board of the Weekly...
news
Launch of the “Heating, Health, Buildings, and Urban Planning” Network:...
news
